Targeting Cancer Stemness Using Nanotechnology in a Holistic Approach: A Narrative Review
Increasing evidence shows that a very small population of cancer stem cells (CSCs) is responsible for cancer recurrence, drug resistance, and metastasis. CSCs usually reside in hypoxic tumor regions and are characterized by high tumorigenicity. Their inaccessible nature allows them to avoid the effe...
Saved in:
| Main Authors: | Melinda-Ildiko Mitranovici, Laura Georgiana Caravia, Liviu Moraru, Lucian Pușcașiu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/3/277 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments – a state-of-the-art update
by: Neevashini Chengebroyen, et al.
Published: (2025-08-01) -
Nanotechnology in cancer treatment: revolutionizing strategies against drug resistance
by: Shazia Sabir, et al.
Published: (2025-04-01) -
Applications of Nanotechnology in Drug Delivery Systems
by: Humphrey Samuel, et al.
Published: (2024-09-01) -
Environmentally benign nanotechnology: transforming elements into nano-agrochemicals for sustainable farming
by: Divya Yadav, et al.
Published: (2025-05-01) -
Glioblastoma Multiformе Tumour Stem Cells as Potential Therapeutic Targets
by: O. A. Beylerli, et al.
Published: (2019-11-01)